Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

CSF Alanine

Body Fluids

Cerebrospinal fluid alanineCSF Ala

Review status

Currently under review

Pending specialist review and validation.

What it shows

CSF Alanine measures the amount of the amino acid alanine in your cerebrospinal fluid, the clear fluid that surrounds your brain and spinal cord. Alanine is made when your body shifts pyruvate into an amino acid during normal energy metabolism, and levels in the fluid around the brain can reflect what is happening inside nervous system cells.

This test is usually performed on a small sample collected by lumbar puncture. It is often ordered as part of a broader CSF metabolic workup, sometimes alongside lactate, pyruvate, and a full amino acid profile, to look for patterns that may explain neurologic symptoms.

Why it matters

Clinicians use CSF alanine to help evaluate suspected inherited metabolic disorders and conditions that affect cellular energy production, such as mitochondrial disease or problems with pyruvate handling. When interpreted together with lactate, pyruvate, and blood or urine studies, alanine patterns can support or argue against specific metabolic causes of seizures, developmental delay, regression, or unexplained neurologic episodes.

The result does not make a diagnosis by itself, but it helps guide the next steps. It can point your care team toward targeted follow up testing, monitoring, and treatments if a metabolic condition is suspected.

Understanding your results

Your provider will interpret your result in the context of your age, symptoms, and related tests. Small deviations can occur because of diet, recent illness, or how the sample was collected, and may not signal a problem. Patterns across several markers are often more informative than any single value, and many conditions require confirmation with additional testing.

Depending on the findings, you may be asked to repeat the test or to have complementary studies, such as plasma amino acids, lactate and pyruvate, urine organic acids, imaging, or genetic testing. If the results suggest a metabolic disorder, early referral to a metabolic or neurometabolic specialist can help with diagnosis and care planning.

Reference ranges

442 umol/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact CSF Alanine

  • Blood contamination of CSF

    Red blood cells from a traumatic tap can leak amino acids into the specimen and falsely raise alanine. Using a later collection tube and minimizing visible blood in the sample reduce this risk.

  • Diet and fasting state

    Recent high protein intake, prolonged fasting, or catabolic stress can change amino acid patterns. Tell your clinician about your recent diet and any intercurrent illness when the sample was taken.

  • Specimen handling and storage

    Amino acids are most stable when the CSF is promptly separated and frozen. Delays in processing, exposure to room temperature, or repeated freeze–thaw cycles can alter results.

  • Medications and therapies

    Valproate, ketogenic diet, corticosteroids, and total parenteral nutrition can influence amino acid metabolism. Provide a complete list of medications and supplements before testing.

  • Age and physiologic stress

    Newborns and young infants can have different baseline amino acid patterns. Fever, seizures, or recent strenuous illness may also shift metabolism and affect results.

  • Central nervous system inflammation

    Meningitis, encephalitis, or other inflammatory conditions can modify CSF composition. Your provider will consider clinical context and other CSF findings when interpreting the result.

2026

References

  1. McGill University Health Centre. (2006, September 13). CSF Alanine (Task CD 693403). Laboratory reference ranges.
  2. Parikh, S., Goldstein, A., Koenig, M. K., Scaglia, F., Enns, G. M., & Saneto, R. (2015). Diagnosis and management of mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society. Genetics in Medicine, 17(9), 689-701.